An AI-enabled precision diagnostics platform for women’s health and fertility.

Evvy is developing technologies for one of the largest underserved markets in the US: the tens of millions of women living with gynecologic conditions that are systematically underdiagnosed, undertreated, and poorly understood by conventional care. Their proprietary at-home diagnostic platform analyzes 700+ biological markers from a single self-administered swab, generating clinically validated insights that drive personalized treatment protocols across fertility, sexual health, gynecologic oncology, and other conditions costing the system $180B+ annually. In just a few years, Evvy's platform has already scaled to over 100,000 patients and 2,000 practitioners nationwide, with published clinical data demonstrating measurable improvements in patient outcomes.